Kumar S, Harrison S, Cavo M, et al. A phase 3 study of venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. 24th Congress of EHA, abstract LB2601.
Sekseverschil bij auto-immuunziekten factor van betekenis
mrt 2022 | Benigne hematologie